USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Reimbursement Cuts and Hospital Consolidation Impede Uptake of Automated Equipment in Laboratories
03-Dec-2013
North America
Market Research
NC76-01-00-00-00
LS00040-NA-MR_16881
This study investigates the global tissue diagnostics market for the period 2009 to 2017. The geographic regions are the US, Western Europe, APAC, and ROW through which the market is broadly classified by the advance stains segment and the pre-analytical segment. The study also includes a competitive analysis (SWOT), product analysis, revenue forecasts, and market shares for the segments. Major market drivers and restraints for the US and Western Europe are discussed. The base year is 2012, and the forecast period runs from 2013 to 2017. Key histo-pathology laboratories are listed, and an effort has been made to collect the distributors and local suppliers in emerging countries.
Key Findings
Key Findings (continued)
Scope and Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements
CEO’s Perspective
Key Companies to Watch
Executive Summary—3 Big Predictions
Market Background
Market Background (continued)
Market Background (continued)
Market Segmentation
Global Market Perspective
Defining Healthcare Trends in the Future
Defining Healthcare Trends in the Future (continued)
New Market Opportunities
New Market Opportunities (continued)
New Market Opportunities (continued)
New Market Opportunities (continued)
Merger, Acquisition, and Partnership Assessment
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Merger, Acquisition, and Partnership Assessment (continued)
Market Engineering Measurements
Forecast Assumptions and Definitions
Forecast Assumptions and Definitions (continued)
Global Revenue Forecast
Global Revenue Forecast by Segment
Global Percent Revenue Forecast by Region
Global Revenue Forecast by Region
Global Revenue Forecast Discussion
Global Revenue Forecast Discussion (continued)
Global Revenue Forecast Discussion (continued)
Procurement Process
Competitive Environment
Product Analysis
Product Analysis (continued)
Top Competitors
Top Competitors (continued)
Top Competitors (continued)
Top Competitors (continued)
Top Competitors (continued)
Market Analysis—US Tissue Diagnostics Market
Key Findings—US Tissue Diagnostics Market
PEST Analysis—US Tissue Diagnostics Market
US Market Drivers
US Market Restraints
Market Impact of Top Trends
Market Engineering Measurements—US Tissue Diagnostics Market
Revenue Forecast—US Tissue Diagnostics Market
Revenue Forecast Discussion—US Tissue Diagnostics Market
US—Market Share by Tier
US—Tier Analysis
US—Tier Analysis (continued)
US—Tier Analysis (continued)
US—Companion Diagnostics Partnerships
US—Pricing Analysis
US—Pricing Analysis (continued)
US—Changes to Pathology CPT Codes
US—Changes to Pathology CPT Codes (continued)
US—Key Tissue Diagnostic Service Providers
Revenue Forecast—US Pre-analytical Segment
Revenue Forecast Discussion Pre-analytical Segment
Revenue Forecast—US Advance Stains Segment
Revenue Forecast Discussion—US Advance stains Segment
Market Analysis
Key Findings—Western European Tissue Diagnostics Market
PEST Analysis—Western European Tissue Diagnostics Market
PEST Analysis—Western European Tissue Diagnostics Market (continued)
Western European Market Drivers
Western European Market Restraints
Market Impact of Top 8 Trends
Market Engineering Measurements
Revenue Forecast—Western European Tissue Diagnostics Market
Revenue Forecast by Segment Type
Revenue Forecasts Discussion
Revenue Forecast Discussion (continued)
Revenue Forecast Discussion (continued)
Western Europe—Market Share by Tier
Western Europe—Tier Analysis
Western Europe—Tier Analysis (continued)
Western Europe—Tier Analysis (continued)
Key Tissue Diagnostic Service Providers
Key Tissue Diagnostic Service Providers (continued)
Key Tissue Diagnostic Service Providers (continued)
Tissue Diagnostics Market Outlook in Western Europe
Western European Tissue Diagnostics Market—Percent Regional Analysis
Germany—Overview
Germany—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
France—Overview
France—Revenue Forecast
Revenue Forecast Discussion
UK—Overview
UK—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Italy—Overview
Italy—Revenue Forecast
Revenue Forecast Discussion
Spain—Overview
Spain—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Revenue Forecast Discussion (continued)
Benelux Overview
Benelux—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Scandinavia Overview
Scandinavia—Revenue Forecast
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Market Analysis
Key Findings—APAC and ROW Tissue Diagnostics Market
PEST Analysis—APAC and ROW Tissue Diagnostics Market
Market Engineering Measurements
Revenue Forecast—Total APAC and ROW Tissue Diagnostics Market
Revenue Forecast by Segment—APAC and ROW Tissue Diagnostics Market
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Revenue Forecast Discussion (continued)
APAC and ROW—Market Share by Tier
Market Share Analysis APAC and ROW
Country Trends
Country Trends (continued)
Country Trends (continued)
Country Trends (continued)
Country Trends (continued)
Country Trends (continued)
Country Trends (continued)
Advanced Cell Diagnostics (ACD)
Biomarker Strategies LLC
HistoRx (Genoptix a Novartis Company)
The Last Word—Three Big Predictions
The Last Word—Discussion
The Last Word—Discussion (continued)
The Last Word—Discussion (continued)
The Last Word—Discussion (continued)
Legal Disclaimer
List of ‘Other’ Companies
Table of Pricing Data
Table of Pricing Data (continued)
Table of Pricing Data (continued)
Table of Pricing Data (continued)
Table of Pricing Data (continued)
Table of Pricing Data (continued)
US—Table of CPT Code Descriptions
US—Table of Cancer Prevalence Trends to 2020
US—Drivers Explained
US—Drivers Explained (continued)
US—Drivers Explained (continued)
US—Drivers Explained (continued)
US—Restraints Explained
US—Restraints Explained (continued)
US—Restraints Explained (continued)
US—Restraints Explained (continued)
Western Europe—Drivers Explained
Western Europe—Drivers Explained (continued)
Western Europe—Drivers Explained (continued)
Western Europe—Drivers Explained (continued)
Western Europe—Restraints Explained
Western Europe—Restraints Explained (continued)
Western Europe—Restraints Explained (continued)
Western Europe—Restraints Explained (continued)
Western Europe—Restraints Explained (continued)
Western Europe—Restraints Explained (continued)
Associated Multimedia
Decision Support Database
Decision Support Database (continued)
Decision Support Database (continued)
Decision Support Database (continued)
Decision Support Database (continued)
Decision Support Database (continued)
Decision Support Database (continued)
Decision Support Database (continued)
Decision Support Database (continued)
Decision Support Database (continued)
Market Engineering Methodology
Learn More—Next Steps
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Divyaa Ravishankar |
| WIP Number | NC76-01-00-00-00 |
| Is Prebook | No |
Analysis of the Global Tissue Diagnostics Market
$10,000.00
Special Price $7,500.00 save 25 %